MYLAN PHARMACEUTICALS

Business Nature: Pharmaceutical Manufacturer and Distributor

Company Overview:

Mylan Taiwan Co., Ltd. is a subsidiary of the global healthcare company Viatris (formed by the merger of Mylan and Upjohn). The company operates as a significant player in the Taiwanese pharmaceutical market, focusing on the supply and distribution of a broad portfolio of high-quality medicines.

Regarding its operational classification, Mylan Taiwan functions as a hybrid entity. It maintains manufacturing capabilities and quality control operations to ensure the production of essential medications while simultaneously acting as a commercial entity responsible for the marketing, sales, and distribution of its pharmaceutical products across the region. It is recognized primarily as a pharmaceutical manufacturer with integrated trading and supply chain operations.

Key Focus:

The company is dedicated to providing access to affordable, high-quality medicine, including chronic disease treatments, generic drugs, and specialized therapeutic solutions. It adheres to international manufacturing standards and local regulatory requirements to ensure patient safety and product efficacy in the Taiwan market.

Mylan Pharmaceuticals Taiwan Ltd. distributes a wide range of pharmaceutical products. Key product categories and examples include:

Cardiovascular Medications

Amlodipine (for hypertension)

Atorvastatin (for cholesterol management)

Valsartan (for hypertension and heart failure)

Central Nervous System Medications

Escitalopram (for depression and anxiety)

Quetiapine (for schizophrenia and bipolar disorder)

Gastrointestinal Medications

Esomeprazole (for acid reflux and gastric ulcers)

Pantoprazole (for acid-related disorders)

Respiratory Medications

Budesonide (for asthma and COPD management)

Salmeterol/Fluticasone (for asthma maintenance)

Anti-Infective Medications

Various generic antibiotics and antiviral agents

Oncology and Specialized Medications

Various oncology products and complex generics for chronic diseases

Note: Product availability may vary based on local regulatory approvals and market supply. For a comprehensive or updated list, please consult the official Taiwan Food and Drug Administration (TFDA) database or the Viatris/Mylan Taiwan corporate website.